News Article 2024

 Home / News / 2024

January 12 2024, David R Brown

Disproquima extends its global life science footprint to Italy with the acquisition of Res Pharma

Disproquima, an international family-owned company with over 50 years of experience in the Life Science Industry, has successfully completed the acquisition of Res Pharma, a well-known Italian company specialising in providing top-quality ingredients for the cosmetic, pharmaceutical, food, and nutraceutical industries.

Together, we can leverage our strengths to create a more significant impact on the global Life Science Industry

Letizia Facchini
President at Res Pharma

The acquisition of Res Pharma strategically expands Disproquima's portfolio of raw materials and ingredients across various sectors and strengthens its position in life science markets globally. The move reflects Disproquima's commitment to providing clients with an even broader range of innovative, sustainable, and market-focused solutions.

“We are thrilled to announce the acquisition of Res Pharma, a company that shares our commitment to excellence and innovation in the Life Science Industry,” said Jordi Sánchez, CEO at Disproquima. “This strategic move allows us to enhance our capabilities and further support our clients with a comprehensive suite of products and services.rdquo;

Res Pharma has a rich history spanning 60 years and has been a key player in carefully selecting and providing top-tier ingredients to its clients in Italy. The company's dedication to offering 360° solutions, encompassing innovation, sustainability, and current market trends, aligns seamlessly with Disproquima's values and vision for the future.

“This acquisition marks an exciting chapter for Res Pharma,rdquo; stated Letizia Facchini, President at Res Pharma. “Joining forces with Disproquima opens up new opportunities for us to continue delivering exceptional value to our customers. Together, we can leverage our strengths to create a more significant impact on the global Life Science Industry.rdquo;

The combination of Disproquima and Res Pharma is expected to harness the collective expertise of both companies to provide clients with unparalleled sales and marketing advice, quality and regulatory support, efficient logistics, and full transparency. The synergy will benefit clients across the Pharma, Dietary Supplements, Food & Beverage, Personal Care, and Animal Nutrition Industries.

About Disproquima
Founded in 1974, Disproquima is an international distributor of raw materials and ingredients for life science industries including Pharmaceuticals, Food and Nutrition, Personal Care and Animal Feed. With extensive experience, technical expertise and employing more than 150 people across four continents, Disproquima provides sales & marketing advice, quality & regulatory support, efficient logistics from 14 offices and 5 laboratories worldwide.

Source(s): Disproquima Press Release

Further Information

Visit: https://www.disproquima.com